STOUGHTON, Mass. (AP) _ Collegium Pharmaceutical Inc. (COLL) on Thursday reported first-quarter net income of $450,000, after reporting a loss in the same period a year earlier.

The Stoughton, Massachusetts-based company said it had profit of 1 cent per share.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 32 cents per share.

The specialty pharmaceutical company posted revenue of $76.5 million in the period, also missing Street forecasts. Six analysts surveyed by Zacks expected $76.6 million.

Collegium Pharmaceutical shares have dropped 1% since the beginning of the year. The stock has increased 45% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on COLL at https://www.zacks.com/ap/COLL

Automated Insights, source Associated Press News